{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:59:34Z","timestamp":1791849574153,"version":"4.3.4"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.cld.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T04:15:07Z","timestamp":1615522507000},"page":"393-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Diagnosis and Management of Hepatic Encephalopathy"],"prefix":"10.1016","volume":"25","author":[{"given":"Marika","family":"Rudler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Bouzbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.cld.2021.01.008_bib3","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ajg.2010.413","article-title":"Minimal hepatic encephalopathy is associated with falls","volume":"106","author":"Rom\u00e1n","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MCG.0000000000000764","article-title":"Covert hepatic encephalopathy: can my patient drive?","volume":"51","author":"Shaw","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cld.2020.01.006","article-title":"The health care burden of hepatic encephalopathy","volume":"24","author":"Elsaid","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-G\u00f3mez","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00134-017-4845-6","article-title":"Understanding hepatic encephalopathy","volume":"44","author":"Weiss","year":"2018","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","article-title":"Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis","volume":"40","author":"Shawcross","year":"2004","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11011-006-9042-1","article-title":"Role of ammonia and inflammation in minimal hepatic encephalopathy","volume":"22","author":"Shawcross","year":"2007","journal-title":"Metab Brain Dis"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.aohep.2019.06.007","article-title":"Association between sarcopenia and hepatic encephalopathy: a systematic review and meta-analysis","volume":"19","author":"Wijarnpreecha","year":"2020","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib12","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1002\/hep.30692","article-title":"Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.008_bib13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/hep.1840150615","article-title":"Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure","volume":"15","author":"Kato","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.008_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11011-005-7913-5","article-title":"Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy","volume":"20","author":"Romero-G\u00f3mez","year":"2005","journal-title":"Metab Brain Dis"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.clinph.2019.03.011","article-title":"GABA-ergic tone hypothesis in hepatic encephalopathy - revisited","volume":"130","author":"Groiss","year":"2019","journal-title":"Clin Neurophysiol"},{"issue":"3\u20134","key":"10.1016\/j.cld.2021.01.008_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000233254","article-title":"Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy","volume":"24","author":"Palomero-Gallagher","year":"2009","journal-title":"Cell Physiol Biochem"},{"issue":"8","key":"10.1016\/j.cld.2021.01.008_bib17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/liv.13061","article-title":"Hepatic vs. drug-induced encephalopathy in cirrhotic patients?","volume":"36","author":"Weiss","year":"2016","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2016.07.046","article-title":"Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy","volume":"65","author":"Weiss","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib19","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1053\/j.gastro.2019.01.033","article-title":"Long-term outcomes of fecal microbiota transplantation in patients with cirrhosis","volume":"156","author":"Bajaj","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib20","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","article-title":"Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial","volume":"66","author":"Bajaj","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ncl.2009.09.016","article-title":"Neurologic presentations of hepatic disease","volume":"28","author":"Harris","year":"2010","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02081027","article-title":"Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation","volume":"10","author":"Weissenborn","year":"1995","journal-title":"Metab Brain Dis"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12028-017-0435-2","article-title":"Electro-radiological observations of grade III\/IV hepatic encephalopathy patients with seizures","volume":"28","author":"Newey","year":"2018","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12028-014-0078-5","article-title":"FOUR score, a reliable score for assessing overt hepatic encephalopathy in cirrhotic patients","volume":"22","author":"Mouri","year":"2015","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01477-8","article-title":"Correlation between ammonia levels and the severity of hepatic encephalopathy","volume":"114","author":"Ong","year":"2003","journal-title":"Am J Med"},{"issue":"3\u20134","key":"10.1016\/j.cld.2021.01.008_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1023\/B:MEBR.0000043980.74574.eb","article-title":"Blood ammonia levels and hepatic encephalopathy","volume":"19","author":"Lockwood","year":"2004","journal-title":"Metab Brain Dis"},{"issue":"4","key":"10.1016\/j.cld.2021.01.008_bib27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00436-1","article-title":"Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy","volume":"38","author":"Nicolao","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.clinre.2018.01.004","article-title":"Why and when to measure ammonemia in cirrhosis?","volume":"42","author":"Mallet","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1665-2681(19)31392-4","article-title":"How to diagnose hepatic encephalopathy in the emergency department","volume":"12","author":"Gundling","year":"2013","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.30534","article-title":"Prognostic role of ammonia in patients with cirrhosis","volume":"70","author":"Shalimar","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cgh.2015.11.018","article-title":"Fasting blood ammonia predicts risk and frequency of hepatic encephalopathy episodes in patients with cirrhosis","volume":"14","author":"Vierling","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2015.11.005","article-title":"Glutamine and hyperammonemic crises in patients with urea cycle disorders","volume":"117","author":"Lee","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib33","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000343","article-title":"Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis","volume":"115","author":"Haj","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.008_bib34","article-title":"Peak hyperammonemia and atypical acute liver failure: the eruption of an urea cycle disorder during hyperemesis gravidarum","author":"Weiss","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib35","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2011.06.085","article-title":"Electroencephalography in patients with cirrhosis","volume":"141","author":"Marchetti","year":"2011","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2021.01.008_bib36","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.clinph.2006.06.714","article-title":"The EEG assessment of low-grade hepatic encephalopathy: comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis","volume":"117","author":"Amodio","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.cld.2021.01.008_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.seizure.2016.12.011","article-title":"Status epilepticus in patients with cirrhosis: how to avoid misdiagnosis in patients with hepatic encephalopathy","volume":"45","author":"Rudler","year":"2017","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib38","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cld.2020.01.011","article-title":"Laboratory abnormalities of hepatic encephalopathy","volume":"24","author":"Karanfilian","year":"2020","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1478-3231.2009.02030.x","article-title":"Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Guerit","year":"2009","journal-title":"Liver Int Off"},{"issue":"8","key":"10.1016\/j.cld.2021.01.008_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/apt.14938","article-title":"Combined diffusion tensor imaging and magnetic resonance spectroscopy to predict neurological outcome before transjugular intrahepatic portosystemic shunt","volume":"48","author":"Rudler","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.cld.2021.01.008_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00234-007-0243-z","article-title":"Manganese accumulation in the brain: MR imaging","volume":"49","author":"Uchino","year":"2007","journal-title":"Neuroradiology"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiology.182.1.1345760","article-title":"Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy","volume":"182","author":"Kreis","year":"1992","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/nbm.1940040214","article-title":"Localized 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols","volume":"4","author":"Kreis","year":"1991","journal-title":"NMR Biomed"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2019.07.008","article-title":"Magnetic resonance spectroscopy: a surrogate marker of hepatic encephalopathy?","volume":"71","author":"Hermann","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2021.01.008_bib45","doi-asserted-by":"crossref","first-page":"e1147","DOI":"10.1212\/WNL.0000000000008899","article-title":"Meta-analysis of magnetic resonance spectroscopy in the diagnosis of hepatic encephalopathy","volume":"94","author":"Zeng","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1750-3639.2004.tb00494.x","article-title":"The neuropathology of septic shock","volume":"14","author":"Sharshar","year":"2004","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.cld.2021.01.008_bib47","doi-asserted-by":"crossref","first-page":"e0153358","DOI":"10.1371\/journal.pone.0153358","article-title":"Frequency and pathophysiology of acute liver failure in ornithine transcarbamylase deficiency (OTCD)","volume":"11","author":"Laemmle","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2021.01.008_bib49","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ajg.2018.6","article-title":"Diagnosis of minimal hepatic encephalopathy: a systematic review of point-of-care diagnostic tests","volume":"113","author":"Tapper","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2021.01.008_bib50","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1053\/j.gastro.2013.12.026","article-title":"Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy","volume":"146","author":"Kircheis","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/jhep.2002.30957","article-title":"Critical flicker frequency for quantification of low-grade hepatic encephalopathy","volume":"35","author":"Kircheis","year":"2002","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.cld.2021.01.008_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.21586","article-title":"Value of the critical flicker frequency in patients with minimal hepatic encephalopathy","volume":"45","author":"Romero-G\u00f3mez","year":"2007","journal-title":"Hepatol Baltim Md"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib53","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1053\/j.gastro.2008.07.021","article-title":"Inhibitory control test for the diagnosis of minimal hepatic encephalopathy","volume":"135","author":"Bajaj","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib54","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2008.06.043","article-title":"Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant","volume":"135","author":"Mardini","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.26309","article-title":"The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy","volume":"58","author":"Bajaj","year":"2013","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The animal naming test: an easy tool for the assessment of hepatic encephalopathy","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.cld.2021.01.008_bib57","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejim.2018.08.008","article-title":"Validation of the simplified animal naming test as primary screening tool for the diagnosis of covert hepatic encephalopathy","volume":"60","author":"Labenz","year":"2019","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib59","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/hep.510240316","article-title":"The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis","volume":"24","author":"Quero","year":"1996","journal-title":"Hepatol Baltim Md"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1515\/cclm-2015-0591","article-title":"First data on the biological variation and quality specifications for plasma ammonia concentrations in healthy subjects","volume":"54","author":"Ucar","year":"2016","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib61","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1034\/j.1600-0676.2002.01431.x","article-title":"Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy","volume":"22","author":"Saxena","year":"2002","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8278(01)00129-5","article-title":"Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients","volume":"35","author":"Amodio","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2021.01.008_bib63","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1440-1746.2010.06596.x","article-title":"Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose","volume":"26","author":"Sharma","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2021.01.008_bib64","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/ajg.2009.293","article-title":"Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis","volume":"104","author":"Guevara","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2021.01.008_bib65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","article-title":"Proton pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a population study","volume":"152","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2021.01.008_bib66","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1053\/j.gastro.2016.10.049","article-title":"Proton pump inhibitor administration triggers encephalopathy in cirrhotic patients by modulating blood-brain barrier drug transport","volume":"152","author":"Assaraf","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.30304","article-title":"Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis","volume":"70","author":"Nardelli","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.008_bib68","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10620-013-3021-2","article-title":"Benzodiazepine-associated hepatic encephalopathy significantly increased healthcare utilization and medical costs of Chinese cirrhotic patients: 7-year experience","volume":"59","author":"Lee","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib69","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.cld.2021.01.008_bib70","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00004836-199008000-00016","article-title":"Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients","volume":"12","author":"Riggio","year":"1990","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.008_bib71","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.28598","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy: a systematic review and meta-analysis","volume":"64","author":"Gluud","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2021.01.008_bib72","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ajg.2012.113","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy","volume":"107","author":"Agrawal","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.008_bib73","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2021.01.008_bib74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.15171\/mejdd.2016.46","article-title":"Polyethylene glycol and lactulose versus lactulose alone in the treatment of hepatic encephalopathy in patients with cirrhosis: a non-inferiority randomized controlled trial","volume":"9","author":"Naderian","year":"2017","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.cld.2021.01.008_bib75","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cld.2021.01.008_bib76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/apt.12803","article-title":"Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy","volume":"40","author":"Kimer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2021.01.008_bib77","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A\u00a0randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.008_bib78","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2021.01.008_bib79","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME trial)","volume":"106","author":"Sidhu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2021.01.008_bib80","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/liv.12921","article-title":"Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy","volume":"36","author":"Sidhu","year":"2016","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib81","article-title":"L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis","author":"Goh","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2021.01.008_bib82","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2036.2002.01191.x","article-title":"Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis","volume":"16","author":"Goulenok","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.cld.2021.01.008_bib83","article-title":"Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy","author":"Goh","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.cld.2021.01.008_bib84","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","author":"Gluud","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.cld.2021.01.008_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/fcp.12340","article-title":"Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study","volume":"32","author":"Weiss","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.cld.2021.01.008_bib86","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/liv.13494","article-title":"The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions","volume":"37","author":"Ganapathy","year":"2017","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib87","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/lt.25420","article-title":"Neurological complications occurring after liver transplantation: role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury","volume":"25","author":"Weiss","year":"2019","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.cld.2021.01.008_bib88","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","article-title":"Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data","volume":"133","author":"Salerno","year":"2007","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2021.01.008_bib89","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","article-title":"Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review","volume":"26","author":"Bai","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"S1","key":"10.1016\/j.cld.2021.01.008_bib90","first-page":"10A","article-title":"Rifaximin reduces hepatic encephalopathy risk after TIPS","volume":"70","author":"Bureau","year":"2019","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326121000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:57:24Z","timestamp":1761069444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326121000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1089326121000088"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2021.01.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Management of Hepatic Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}